Compass Pathways Valuation

CMPS Stock  USD 5.39  -0.25  -4.43%   
At current prices, Compass Pathways appears undervalued. Our estimate of the Real Value of Compass Pathways is $6.24 per share, compared with the current market price of $5.39. This valuation read leans primarily on shares owned by insiders of 8.22% and is then cross-checked against technical indicators and probability of bankruptcy. Key valuation drivers for Compass Pathways include:
 Price Book
16.1106
 Enterprise Value
523.4 M
 Enterprise Value Ebitda
-3.51
Undervalued
Today
5.39
Right now, the market is showing Elevated price fluctuation for Compass Pathways. The real value model for Compass Pathways Plc currently uses a 3 months horizon. Increasing the horizon tends to sharpen the value estimate and improve the signal quality behind the methodology.
Fair value for the Compass stock can be framed as the amount a typical acquirer may be willing to pay for all or part of Compass Pathways Plc. As Compass Pathways trades in the market, its quoted value is determined by buyers and sellers rather than by the model alone. Its market price can differ from intrinsic value, which may create an opportunity if price and value converge over time.
Historical Market  5.39 Real  6.24 Target  21.67 Hype  5.64 Naive  5.46
Compass Pathways intrinsic value reflects its underlying financial performance and long-term growth potential. Intrinsic value for Compass Pathways is typically estimated using discounted cash flow or earnings-based approaches.
6.24
Real Value
12.22
Upside
Forecasting the upside and downside scenarios for Compass Pathways Plc allows investors to calibrate position sizing. A complete valuation of Compass considers technical factors, market conditions, and broader macro trends.
Earnings
Estimates
LowProjectedHigh
-0.32-0.32-0.32
Details
Hype
Prediction
LowEstimatedHigh
0.285.6411.62
Details
Naive
Forecast
LowNext ValueHigh
0.115.4611.43
Details
Analyst
Consensus
LowTarget PriceHigh
19.7221.6724.05
Details
Institutional participants approach Compass Pathways valuation systematically, starting with intrinsic value. An intrinsic value estimate based on Compass Pathways' projected cash flows is cross-checked against peer multiples.

Main Profitability Drivers

 Price Book
16.1106
 Wall Street Target Price
21.6667
Cash is projected to change by approximately 8.53% year over year. Prior-period financials list Cash at 149.61 Million. As of last month (February 2026), Accounts Payable is projected to grow to approximately 16 M.

Compass Pathways Cash

163.56 Million

Total Value Analysis

The current total-value analysis for Compass Pathways Plc points to enterprise value near 523.39 M, market capitalization around 637.97 M, debt of 20.93 M, and cash balances of 207.18 M. Used properly, enterprise value helps organize the capital-structure picture, but it should still be tested against revenue quality, margins, and broader fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
523.39 M
637.97 M
20.93 M
207.18 M

Asset Utilization

One of the ways to look at asset utilization of Compass is to check how much profit was generated for every dollar of assets it reports. Compass Pathways has a negative application of assets of -0.52%, losing $0.005168 for each dollar of assets held by the company. Inefficient asset utilization attests that the company is being less capable with each dollar of assets it has. Strictly speaking, asset utilization of Compass Pathways Plc shows how inefficient it operates for each dollar spent on its assets.
Macro event markers
 
Covid
 
Interest Hikes

Profitability Analysis

Based on Compass Pathways' profitability indicators, Compass Pathways Plc may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess Compass Pathways' ability to earn profits and add value for shareholders.
 
Net Loss  
 First Reported
2019-03-31
 Previous Quarter
-137.7 M
 Current Value
-93.9 M
 Quarterly Volatility
27.7 M
Macro event markers
 
Covid
 
Interest Hikes
As of last month (February 2026), Gross Profit is forecasted to soften to approximately -220.3 K.
The profitability module for Compass Pathways Plc is designed to show how the business generates income relative to revenue, assets, expenses, and shareholder capital. Used properly, profitability analysis can show what is supporting performance today and what may begin to weaken it later. Compass Pathways currently reports return on equity near -5.65%, which helps anchor profitability expectations.

Earnings per Share Projection vs Actual

EPS projections for Compass Pathways aggregate analyst models into a benchmark against which actual results are measured. Return on equity of -565.28% provides context for how efficiently Compass Pathways generates earnings from shareholder capital. Consensus earnings estimates for Compass Pathways Plc should be reviewed carefully because analyst EPS forecasts are usually built before non-recurring items and option-related expenses are fully unpacked. Compass Pathways is projected to generate -0.32 in earnings per share on 30th of June 2026. The EPS projection range provides context for understanding what analysts currently expect before the next report arrives.
Macro event markers
 
Covid
 
Interest Hikes

Earnings Estimation Breakdown

Analyst consensus for Compass Pathways Plc places the projected EPS at -0.32 for the upcoming period. This estimate is bounded by a low of -0.32 and a high of -0.32 across all analyst models covering Compass Pathways. Trailing twelve-month reporting data forms the basis of this projection, with non-recurring items excluded from the calculation.
Last Reported EPS
0.0
-0.32
Lowest
Expected EPS
-0.32
-0.32
Highest

Earnings Projection Consensus

Valuation signals derived from Compass Pathways' consensus EPS estimate versus market price offer a directional view of relative attractiveness. A positive gap may indicate room for repricing toward the estimate; a negative gap may suggest the market has already priced in growth fully. These scenarios should be reviewed within the context of earnings quality, sector dynamics, and macroeconomic conditions.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
1247.76%
0.0
-0.32
-3.08

Ownership Allocation

About 30% of Compass Pathways outstanding shares are owned by institutions. Institutional investors - such as mutual funds, pension funds, and asset managers - typically hold positions as part of a broader portfolio strategy, managing assets on behalf of clients. As a result, institutional investors are subject to reporting requirements and oversight rules - such as 13F filings - that differ from those for individual retail investors. Changes in institutional ownership of Compass Pathways can sometimes signal a shift in professional sentiment toward the company. The ownership breakdown for Compass Pathways shows approximately 47% institutional, 8% insider, and 45% public.

Revenue and Profit Overview

Net Loss for the year was -287.86 M with profit before overhead, payroll, taxes, and interest of 0.

Valuation Framework, Methodology & Assumptions

Compass Pathways is a small-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Health Care categories. Growth expectations are weighed against macro conditions. Higher beta characteristics could amplify reactions to changes in economic conditions. Compass Pathways currently trades at enterprise value of 523.39 M, P/B of 16.11.

This section for Compass Pathways Plc is built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Analyst inputs may be included when coverage is available. Values may update on different source schedules. Valuation outputs are model-derived and depend on published assumptions and reference inputs.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 14th, 2026

Compass Pathways Current Valuation Indicators

A net-worth review of Compass Pathways Plc links market cap to balance-sheet health, cash flow, and implied growth expectations. Good valuation narrows the range of reasonable outcomes before capital is committed.

Additional Tools for Compass Stock Analysis

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Directory
Find actively traded commodities issued by global exchanges